Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons.

Akolo, Christopher; Bada, Florence; Okpokoro, Evaezi; Nwanne, Ogochukwu; Iziduh, Sharon; Usoroh, Eno; Ali, Taofeekat; Ibeziako, Vivian; Oladimeji, Olanrewaju; Odo, Michael

Akolo, Christopher; Bada, Florence; Okpokoro, Evaezi; Nwanne, Ogochukwu; Iziduh, Sharon; Usoroh, Eno; Ali, Taofeekat; Ibeziako, Vivian; Oladimeji, Olanrewaju; Odo, Michael.

Affiliation

Akolo C; Christopher Akolo, Population Services International, Washington, DC 20036, United States.
Bada F; Christopher Akolo, Population Services International, Washington, DC 20036, United States.
Okpokoro E; Christopher Akolo, Population Services International, Washington, DC 20036, United States.
Nwanne O; Christopher Akolo, Population Services International, Washington, DC 20036, United States.
Iziduh S; Christopher Akolo, Population Services International, Washington, DC 20036, United States.
Usoroh E; Christopher Akolo, Population Services International, Washington, DC 20036, United States.
Ali T; Christopher Akolo, Population Services International, Washington, DC 20036, United States.
Ibeziako V; Christopher Akolo, Population Services International, Washington, DC 20036, United States.
Oladimeji O; Christopher Akolo, Population Services International, Washington, DC 20036, United States.
Odo M; Christopher Akolo, Population Services International, Washington, DC 20036, United States.

World J Virol ; 4(2): 105-12, 2015 May 12.

Article in En | MEDLINE | ID: mdl-25964875

Key words

Chemoprophylaxis; Human immunodeficiency virus; Isoniazid preventive therapy; Tuberculosis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: World J Virol Year: 2015 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google